SOdium-glucose CO-transporter inhibition in patients with newly detected Glucose Abnormalities and a recent Myocardial Infarction (SOCOGAMI)-Reference-Cited by-同舟云学术

SOdium-glucose CO-transporter inhibition in patients with newly detected Glucose Abnormalities and a recent Myocardial Infarction (SOCOGAMI)

Published:2022-11 Issue: Volume:193 Page:110141
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Lundin Magnus,Ferrannini Giulia,Mellbin Linda,Johansson Isabelle,Norhammar Anna,Näsman Per,Shahim Bahira,Smetana Stina,Venkateshvaran Ashwin,Wang Anne,Sörensson Peder,Rydén Lars

Funder

Boehringer Ingelheim International GmbH

Hjärt-Lungfonden

Boehringer Ingelheim

Stockholms Läns Landsting

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference31 articles.

1. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study;Norhammar;Lancet,2002

2. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart;Bartnik;Eur Heart J,2004

3. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020;41(2):255-323.

4. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction;Bartnik;Eur Heart J,2004

5. Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort;Ritsinger;Diab Vasc Dis Res,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empagliflozin Effect on Left Cardiac Parameters in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Cureus;2024-09-11

2. Effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) on N-terminal pro-B-type natriuretic peptide (NT-proBNP) level and structural changes following myocardial infarction: A systematic review and meta-analysis;International Journal of Cardiology;2024-09

3. Safety and efficacy of early initiation of sodium-glucose cotransporter-2 inhibitors after an acute coronary syndrome event: a meta-analysis of randomized controlled trials;European Heart Journal - Cardiovascular Pharmacotherapy;2024-07-17

4. The effect of Empagliflozin on echocardiographic parameters in diabetic patients after acute myocardial infarction: A systematic review and meta-analysis with trial sequential analysis;Irish Journal of Medical Science (1971 -);2024-07-03

5. The effect of SGLT2 inhibitors and GLP1 receptor agonists on arterial stiffness: A meta-analysis of randomized controlled trials;Journal of Diabetes and its Complications;2024-07